|
Real-time
Euronext Bruxelles
17:20:02 31/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 215.40 EUR | -0.51% |
|
-2.09% | -9.72% |
| 08-20 | Cancer vaccines finally garner the spotlight |  |
| 08-19 | Danish Pharma H. Lundbeck Expects No Slowdown for Primary Growth Driver Brands | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- UCB Stock
- Consensus UCB
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
